Cargando…

Age-dependent effect of APOE and polygenic component on Alzheimer's disease

Alzheimer's disease (AD) is a devastating neurodegenerative condition with significant genetic heritability. Several genes have been implicated in the onset of AD with the apolipoprotein E (APOE) gene being the strongest single genetic risk loci. Evidence suggests that the effect of APOE alters...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellou, Eftychia, Baker, Emily, Leonenko, Ganna, Bracher-Smith, Matthew, Daunt, Paula, Menzies, Georgina, Williams, Julie, Escott-Price, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308803/ https://www.ncbi.nlm.nih.gov/pubmed/32464432 http://dx.doi.org/10.1016/j.neurobiolaging.2020.04.024

Ejemplares similares

Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition
por: Leonenko, Ganna, et al.
Publicado: (2019)

Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
por: Leonenko, Ganna, et al.
Publicado: (2021)

Polygenic risk and pleiotropy in neurodegenerative diseases
por: Bellou, Eftychia, et al.
Publicado: (2020)

Whole genome analysis in APOE4 homozygotes identifies the DAB1-RELN pathway in Alzheimer's disease pathogenesis
por: Bracher-Smith, Matthew, et al.
Publicado: (2022)

Polygenic risk and hazard scores for Alzheimer's disease prediction
por: Leonenko, Ganna, et al.
Publicado: (2019)

Golgi apparatus, endoplasmic reticulum and mitochondrial function implicated in Alzheimer’s disease through polygenic risk and RNA sequencing
por: Crawford, Karen, et al.
Publicado: (2022)

Are Alzheimer's and coronary artery diseases genetically related to longevity?
por: Bellou, Eftychia, et al.
Publicado: (2023)

Polygenic Risk Scores in Alzheimer's Disease: Current Applications and Future Directions
por: Baker, Emily, et al.
Publicado: (2020)

Polygenic Risk Score Analysis of Alzheimer’s Disease in Cases without APOE4 or APOE2 Alleles
por: Escott-Price, V., et al.
Publicado: (2018)

Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease
por: Stevenson-Hoare, Joshua, et al.
Publicado: (2022)

Defining functional variants associated with Alzheimer’s disease in the induced immune response
por: Harwood, Janet C, et al.
Publicado: (2021)

Pathway-specific polygenic scores for Alzheimer’s disease are associated with changes in brain structure in younger and older adults
por: Harrison, Judith R, et al.
Publicado: (2023)

Comparison of long-term effects of metformin on longevity between people with type 2 diabetes and matched non-diabetic controls
por: Stevenson-Hoare, Joshua, et al.
Publicado: (2023)

From Polygenic Scores to Precision Medicine in Alzheimer’s Disease: A Systematic Review
por: Harrison, Judith R., et al.
Publicado: (2020)

Polygenic risk for schizophrenia and subcortical brain anatomy in the UK Biobank cohort
por: Grama, Steluta, et al.
Publicado: (2020)

POLARIS: Polygenic LD‐adjusted risk score approach for set‐based analysis of GWAS data
por: Baker, Emily, et al.
Publicado: (2018)

Polygenic resilience scores capture protective genetic effects for Alzheimer’s disease
por: Hou, Jiahui, et al.
Publicado: (2022)

Measuring heritable contributions to Alzheimer’s disease: polygenic risk score analysis with twins
por: Karlsson, Ida K., et al.
Publicado: (2022)

Predictive modeling of schizophrenia from genomic data: Comparison of polygenic risk score with kernel support vector machines approach
por: Vivian‐Griffiths, Timothy, et al.
Publicado: (2018)

What does heritability of Alzheimer’s disease represent?
por: Baker, Emily, et al.
Publicado: (2023)

Utility of Polygenic Risk Scoring to Predict Cognitive Impairment as Measured by Preclinical Alzheimer Cognitive Composite Score
por: Gao, Q., et al.
Publicado: (2022)

Machine learning for prediction of schizophrenia using genetic and demographic factors in the UK biobank
por: Bracher-Smith, Matthew, et al.
Publicado: (2022)

Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder
por: Allardyce, Judith, et al.
Publicado: (2017)

Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE ɛ4 negatives
por: Najar, Jenna, et al.
Publicado: (2021)

Polygenic score modifies risk for Alzheimer's disease in APOE ε4 homozygotes at phenotypic extremes
por: Huq, Aamira J., et al.
Publicado: (2021)

A comprehensive analysis of methods for assessing polygenic burden on Alzheimer’s disease pathology and risk beyond APOE
por: Altmann, Andre, et al.
Publicado: (2019)

Machine learning for the life-time risk prediction of Alzheimer’s disease: a systematic review
por: Rowe, Thomas W, et al.
Publicado: (2021)

Polygenic risk of Parkinson disease is correlated with disease age at onset
por: Escott‐Price, Valentina, et al.
Publicado: (2015)

Genome-wide association studies for Alzheimer’s disease: bigger is not always better
por: Escott-Price, Valentina, et al.
Publicado: (2022)

Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer’s disease biomarkers
por: Kulminski, Alexander M., et al.
Publicado: (2022)

Considering the APOE locus in Alzheimer’s disease polygenic scores in the Health and Retirement Study: a longitudinal panel study
por: Ware, Erin B., et al.
Publicado: (2020)

Association of APOE-Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults
por: Xicota, Laura, et al.
Publicado: (2022)

Probability of Alzheimer’s disease based on common and rare genetic variants
por: Escott-Price, Valentina, et al.
Publicado: (2021)

Correction to: Probability of Alzheimer’s disease based on common and rare genetic variants
por: Escott-Price, Valentina, et al.
Publicado: (2021)

Integrated analysis of direct and proxy genome wide association studies highlights polygenicity of Alzheimer’s disease outside of the APOE region
por: de la Fuente, Javier, et al.
Publicado: (2022)

Association of genetic liability for psychiatric disorders with accelerometer-assessed physical activity in the UK Biobank
por: Dennison, Charlotte A., et al.
Publicado: (2021)

Apolipoprotein E moderates the association between Non-APOE Polygenic Risk Score for Alzheimer’s Disease and Aging on Preclinical Cognitive Function
por: Xu, Yuexuan, et al.
Publicado: (2023)

APOE ɛ4, but not polygenic Alzheimer’s disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals
por: Håglin, Sofia, et al.
Publicado: (2023)

Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk
por: Salih, Dervis A, et al.
Publicado: (2019)

Characterising heart rhythm abnormalities associated with Xp22.31 deletion
por: Wren, Georgina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5o2v3tt7dphcc1eoeic1b8jtgk